{"id":53724,"date":"2026-01-12T13:56:31","date_gmt":"2026-01-12T05:56:31","guid":{"rendered":"https:\/\/flcube.com\/?p=53724"},"modified":"2026-01-12T13:56:32","modified_gmt":"2026-01-12T05:56:32","slug":"johnson-johnson-strikes-tariff-exemption-deal-with-trump-administration","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=53724","title":{"rendered":"Johnson &amp; Johnson Strikes Tariff Exemption Deal with Trump Administration"},"content":{"rendered":"\n<p><strong>Johnson &amp; Johnson (J&amp;J, <a href=\"https:\/\/www.google.com\/finance\/quote\/JNJ:NYSE\">NYSE: JNJ<\/a>)<\/strong> announced a <strong>voluntary agreement<\/strong> with the Trump Administration to improve <strong>medicine access and lower costs<\/strong> for millions of American patients. The agreement grants J&amp;J\u2019s pharmaceutical products <strong>exemption from tariffs<\/strong> and includes participation in <strong>TrumpRx.gov<\/strong>, a direct\u2011to\u2011patient platform enabling purchases at prices comparable to other developed countries. J&amp;J also reaffirmed its <strong>$55\u202fbillion US investment<\/strong> through early\u202f2029.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-agreement-overview\">Agreement Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Company<\/strong><\/td><td>Johnson &amp; Johnson (NYSE: JNJ)<\/td><\/tr><tr><td><strong>Counterparty<\/strong><\/td><td>Trump Administration<\/td><\/tr><tr><td><strong>Tariff Impact<\/strong><\/td><td>Pharmaceutical products exempted from tariffs<\/td><\/tr><tr><td><strong>Platform<\/strong><\/td><td>TrumpRx.gov (direct\u2011to\u2011patient)<\/td><\/tr><tr><td><strong>Pricing Model<\/strong><\/td><td>Prices comparable to other developed countries<\/td><\/tr><tr><td><strong>Medicaid Access<\/strong><\/td><td>Provided at developed\u2011country comparable prices<\/td><\/tr><tr><td><strong>Investment Commitment<\/strong><\/td><td>USD\u202f55\u202fbillion by early\u202f2029 (manufacturing, R&amp;D, technology)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-trumprx-gov-platform-details\">TrumpRx.gov Platform Details<\/h2>\n\n\n\n<p><strong>Key Features<\/strong>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Direct\u2011to\u2011patient sales<\/strong>: Bypasses traditional pharmacy benefit managers (PBMs)<\/li>\n\n\n\n<li><strong>Discounted rates<\/strong>: Enables <strong>millions of Americans<\/strong> to access J&amp;J medicines at <strong>international price parity<\/strong><\/li>\n\n\n\n<li><strong>Medicaid integration<\/strong>: State Medicaid programs can purchase at comparable global prices<\/li>\n\n\n\n<li><strong>Value recognition<\/strong>: Supports Administration&#8217;s efforts to align US healthcare pricing with developed markets<\/li>\n<\/ul>\n\n\n\n<p><strong>Supported Products<\/strong>: Includes <strong>Stelara, Darzalex, Tremfya, Imbruvica<\/strong>, and <strong>Xarelto<\/strong> (full portfolio details pending).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-financial-amp-strategic-implications\">Financial &amp; Strategic Implications<\/h2>\n\n\n\n<p><strong>Immediate Impact<\/strong>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Tariff savings<\/strong>: <strong>2\u20114%<\/strong> cost reduction on US\u2011produced pharmaceuticals (estimated <strong>USD\u202f300\u2011500\u202fmillion<\/strong> annually)<\/li>\n\n\n\n<li><strong>Pricing transparency<\/strong>: Direct\u2011to\u2011consumer model reduces <strong>PBM rebates<\/strong> (historically 30\u201140% of list price)<\/li>\n\n\n\n<li><strong>Market access<\/strong>: Potential <strong>5\u201110\u202fmillion<\/strong> new patients via TrumpRx.gov in first year<\/li>\n<\/ul>\n\n\n\n<p><strong>$55\u202fBillion Investment Breakdown<\/strong>:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Category<\/th><th>Amount (USD\u202fB)<\/th><th>Timeline<\/th><\/tr><\/thead><tbody><tr><td><strong>US Manufacturing<\/strong><\/td><td>25<\/td><td>2026\u20112029<\/td><\/tr><tr><td><strong>R&amp;D &amp; Technology<\/strong><\/td><td>20<\/td><td>2026\u20112029<\/td><\/tr><tr><td><strong>Digital Infrastructure<\/strong><\/td><td>10<\/td><td>2026\u20112028<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Manufacturing<\/strong>: Expansion includes <strong>new biologics plant in North Carolina<\/strong> (capacity: 50M doses\/year) and <strong>vaccine facility in Pennsylvania<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-context-amp-competitive-response\">Market Context &amp; Competitive Response<\/h2>\n\n\n\n<p><strong>Industry Impact<\/strong>: J&amp;J is the <strong>first major pharma<\/strong> to secure <strong>tariff exemption<\/strong> and join TrumpRx.gov, potentially pressuring <strong>Pfizer, Merck, and Eli Lilly<\/strong> to follow suit.<\/p>\n\n\n\n<p><strong>Stock Reaction<\/strong>: J&amp;J shares rose <strong>2.1%<\/strong> on the news, reflecting investor optimism on <strong>margin protection<\/strong> and <strong>expanded US market access<\/strong>.<\/p>\n\n\n\n<p><strong>Political Risk<\/strong>: Agreement contingent on <strong>continued Trump Administration policies<\/strong>; mid\u2011term elections could reintroduce pricing pressures.<\/p>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding the financial impact of the Trump Administration agreement, TrumpRx.gov enrollment projections, and J&amp;J\u2019s US investment execution. Actual results may differ materially due to political changes, competitive dynamics, and regulatory implementation.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Johnson &amp; Johnson (J&amp;J, NYSE: JNJ) announced a voluntary agreement with the Trump Administration to&#8230;<\/p>\n","protected":false},"author":1,"featured_media":53725,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1],"tags":[150,149,858],"class_list":["post-53724","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-jj","tag-johnson-johnson","tag-nyse-jnj"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Johnson &amp; Johnson Strikes Tariff Exemption Deal with Trump Administration - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Johnson &amp; Johnson (J&amp;J, NYSE: JNJ) announced a voluntary agreement with the Trump Administration to improve medicine access and lower costs for millions of American patients. The agreement grants J&amp;J\u2019s pharmaceutical products exemption from tariffs and includes participation in TrumpRx.gov, a direct\u2011to\u2011patient platform enabling purchases at prices comparable to other developed countries. J&amp;J also reaffirmed its $55\u202fbillion US investment through early\u202f2029.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=53724\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Johnson &amp; Johnson Strikes Tariff Exemption Deal with Trump Administration\" \/>\n<meta property=\"og:description\" content=\"Johnson &amp; Johnson (J&amp;J, NYSE: JNJ) announced a voluntary agreement with the Trump Administration to improve medicine access and lower costs for millions of American patients. The agreement grants J&amp;J\u2019s pharmaceutical products exemption from tariffs and includes participation in TrumpRx.gov, a direct\u2011to\u2011patient platform enabling purchases at prices comparable to other developed countries. J&amp;J also reaffirmed its $55\u202fbillion US investment through early\u202f2029.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=53724\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-12T05:56:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-12T05:56:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/1201.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=53724#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=53724\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Johnson &amp; Johnson Strikes Tariff Exemption Deal with Trump Administration\",\"datePublished\":\"2026-01-12T05:56:31+00:00\",\"dateModified\":\"2026-01-12T05:56:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=53724\"},\"wordCount\":400,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=53724#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/1201.webp\",\"keywords\":[\"J&amp;J\",\"Johnson &amp; Johnson\",\"NYSE: JNJ\"],\"articleSection\":[\"Others\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=53724#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=53724\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=53724\",\"name\":\"Johnson &amp; Johnson Strikes Tariff Exemption Deal with Trump Administration - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=53724#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=53724#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/1201.webp\",\"datePublished\":\"2026-01-12T05:56:31+00:00\",\"dateModified\":\"2026-01-12T05:56:32+00:00\",\"description\":\"Johnson & Johnson (J&J, NYSE: JNJ) announced a voluntary agreement with the Trump Administration to improve medicine access and lower costs for millions of American patients. The agreement grants J&J\u2019s pharmaceutical products exemption from tariffs and includes participation in TrumpRx.gov, a direct\u2011to\u2011patient platform enabling purchases at prices comparable to other developed countries. J&J also reaffirmed its $55\u202fbillion US investment through early\u202f2029.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=53724#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=53724\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=53724#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/1201.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/1201.webp\",\"width\":1080,\"height\":608,\"caption\":\"Johnson & Johnson Strikes Tariff Exemption Deal with Trump Administration\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=53724#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Johnson &amp; Johnson Strikes Tariff Exemption Deal with Trump Administration\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Johnson &amp; Johnson Strikes Tariff Exemption Deal with Trump Administration - Insight, China&#039;s Pharmaceutical Industry","description":"Johnson & Johnson (J&J, NYSE: JNJ) announced a voluntary agreement with the Trump Administration to improve medicine access and lower costs for millions of American patients. The agreement grants J&J\u2019s pharmaceutical products exemption from tariffs and includes participation in TrumpRx.gov, a direct\u2011to\u2011patient platform enabling purchases at prices comparable to other developed countries. J&J also reaffirmed its $55\u202fbillion US investment through early\u202f2029.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=53724","og_locale":"en_US","og_type":"article","og_title":"Johnson &amp; Johnson Strikes Tariff Exemption Deal with Trump Administration","og_description":"Johnson & Johnson (J&J, NYSE: JNJ) announced a voluntary agreement with the Trump Administration to improve medicine access and lower costs for millions of American patients. The agreement grants J&J\u2019s pharmaceutical products exemption from tariffs and includes participation in TrumpRx.gov, a direct\u2011to\u2011patient platform enabling purchases at prices comparable to other developed countries. J&J also reaffirmed its $55\u202fbillion US investment through early\u202f2029.","og_url":"https:\/\/flcube.com\/?p=53724","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-01-12T05:56:31+00:00","article_modified_time":"2026-01-12T05:56:32+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/1201.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=53724#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=53724"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Johnson &amp; Johnson Strikes Tariff Exemption Deal with Trump Administration","datePublished":"2026-01-12T05:56:31+00:00","dateModified":"2026-01-12T05:56:32+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=53724"},"wordCount":400,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=53724#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/1201.webp","keywords":["J&amp;J","Johnson &amp; Johnson","NYSE: JNJ"],"articleSection":["Others"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=53724#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=53724","url":"https:\/\/flcube.com\/?p=53724","name":"Johnson &amp; Johnson Strikes Tariff Exemption Deal with Trump Administration - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=53724#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=53724#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/1201.webp","datePublished":"2026-01-12T05:56:31+00:00","dateModified":"2026-01-12T05:56:32+00:00","description":"Johnson & Johnson (J&J, NYSE: JNJ) announced a voluntary agreement with the Trump Administration to improve medicine access and lower costs for millions of American patients. The agreement grants J&J\u2019s pharmaceutical products exemption from tariffs and includes participation in TrumpRx.gov, a direct\u2011to\u2011patient platform enabling purchases at prices comparable to other developed countries. J&J also reaffirmed its $55\u202fbillion US investment through early\u202f2029.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=53724#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=53724"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=53724#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/1201.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/1201.webp","width":1080,"height":608,"caption":"Johnson & Johnson Strikes Tariff Exemption Deal with Trump Administration"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=53724#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Johnson &amp; Johnson Strikes Tariff Exemption Deal with Trump Administration"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/1201.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/53724","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=53724"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/53724\/revisions"}],"predecessor-version":[{"id":53726,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/53724\/revisions\/53726"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/53725"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=53724"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=53724"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=53724"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}